Overview

The investigators propose to develop and adapt 'ANZEILAX' smartphone app specifically for individuals with Generalized anxiety disorder. The study will measure the therapeutic effects and safety of 'ANZEILAX' on symptoms of anxiety using pre- and post-treatment scores for generalized anxiety disorder and other physical, emotional, and cognitive symptoms of anxiety

Eligibility

Inclusion Criteria:

People can participate in this clinical trial only if following criteria are met.

1. Adults aged 19 years or older with a high school diploma or higher
2. Disease groups according to the criteria below:
   • A person diagnosed with Generalized Anxiety Disorder (DSM-5 (ICD-10) code: 300.02 (F41.1))
   • Those who are classified as moderate or severe with 10 points or more through GAD-7
   • Those taking prescription drugs related to generalized anxiety disorder
3. A group of disorders with generalized anxiety disorder, or a group of disorders with

   worry that is a major symptom of generalized anxiety disorder in any of the following

   criteria

   • Those suffering from other anxiety disorders such as panic disorder and social anxiety disorder
   • Those suffering from major depressive disorder accompanied by worry, the main symptom of generalized anxiety disorder

4. A person who fully understands the purpose, contents, and process of the clinical

   trial, agrees to participate, and signs the consent form in handwriting

Exclusion Criteria:

        If any of the following criteria is applicable, the person cannot participate in this
        clinical trial.
          1. Those who cannot read the consent form
          2. Those who are inexperienced in using smartphones
          3. In case of psychiatric symptoms or history (including schizophrenia, psychosis,
             bipolar disorder, epilepsy)
          4. In case of brain damage, cognitive impairment, or neurological disease
          5. In case of intellectual disability
          6. Having a substance and alcohol use disorder
          7. Suicidal intent, suicidal ideation, or self-injurious behavior in the past 6 months
          8. Receiving cognitive behavioral therapy for anxiety, depression or mood disorders, or
             participating in such therapy in the past 3 months
          9. Those who are registered in other clinical studies
         10. Other investigators judged that the conduct of this clinical trial was inappropriate